Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Do β-Blockers Cause Depression?
Thomas G. Riemer, Linda Elizabeth Villagómez Fuentes, Engi Algharably, et al.
Hypertension (2021) Vol. 77, Iss. 5, pp. 1539-1548
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1507
Severe Mental Illness and Cardiovascular Disease
Michael Goldfarb, Marc D. Binder, Johan Detraux, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 9, pp. 918-933
Open Access | Times Cited: 90
Individualized Beta-Blocker Treatment for High Blood Pressure Dictated by Medical Comorbidities: Indications Beyond the 2018 European Society of Cardiology/European Society of Hypertension Guidelines
Giuseppe Mancia, Sverre E. Kjeldsen, Reinhold Kreutz, et al.
Hypertension (2022) Vol. 79, Iss. 6, pp. 1153-1166
Open Access | Times Cited: 53
Safety and tolerability of β-blockers: importance of cardioselectivity
Hans‐Peter Marti, Abel Alberto Pavía López, Pedro Vellosa Schwartzmann
Current Medical Research and Opinion (2024) Vol. 40, Iss. sup1, pp. 55-62
Open Access | Times Cited: 11
Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populations
Bohan Fan, Jie Zhao
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8
Rationale for the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines
Giuseppe Mancia, Mattias Brunström, Michel Burnier, et al.
Hypertension (2024) Vol. 81, Iss. 5, pp. 1021-1030
Open Access | Times Cited: 6
Pathophysiological mechanisms of post-myocardial infarction depression: a narrative review
Eric Garrels, Tejasvi Kainth, Briana Silva, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 14
The 2023 Canadian Cardiovascular Society Clinical Practice Update on Management of the Patient With a Prolonged QT Interval
Ross A. Davies, Virginie Beauséjour Ladouceur, Martin S. Green, et al.
Canadian Journal of Cardiology (2023) Vol. 39, Iss. 10, pp. 1285-1301
Open Access | Times Cited: 14
Beta-blockers for electroconvulsive therapy: A systematic review and meta-analysis
Toshiyuki Shimizu, Yoshiteru Takekita, Nobuatsu Aoki, et al.
Journal of Psychiatric Research (2025) Vol. 183, pp. 269-281
Open Access
Pharmacological and psychological approaches to insomnia treatment in cardiac patients: a narrative literature review
Britta Stapel, Marlies Alvarenga, Kai G. Kahl
Frontiers in Psychiatry (2025) Vol. 16
Open Access
Association between antihypertensive drug use and the risk of depression: a systematic review and network meta-analysis
Jay Tewari, Khalid Ahmad Qidwai, Ajoy Tewari, et al.
Journal of Human Hypertension (2025)
Closed Access
Associations between β-blockers and psychiatric and behavioural outcomes: A population-based cohort study of 1.4 million individuals in Sweden
Yasmina Molero, Sam Kaddoura, Ralf Kuja‐Halkola, et al.
PLoS Medicine (2023) Vol. 20, Iss. 1, pp. e1004164-e1004164
Open Access | Times Cited: 11
Pharmacologic Management of Heart Failure with Preserved Ejection Fraction (HFpEF) in Older Adults
Ashkan Hashemi, Min Ji Kwak, Parag Goyal
Drugs & Aging (2025)
Closed Access
Comorbidity Between Mental and Physical Disorders in Children and Adolescents: Identification, Management, and Treatment
Daniele Marcotulli, Anna Salvalaggio, Anita Zardini, et al.
(2025), pp. 275-298
Closed Access
Calcium channel blockers and mental health: a comprehensive meta-analysis of psychiatric adverse events in double-blind randomized controlled trials
Marc-Alexander Fürtig, Yana Kovalenko, Reinhold Kreutz, et al.
Journal of Hypertension (2025)
Closed Access
Manual acupuncture enhanced therapeutic efficacy in vascular dementia rat model: systematic review and network meta-analysis
Yuanyu Song, Yinghua Chen, Junfeng Li, et al.
Systematic Reviews (2025) Vol. 14, Iss. 1
Open Access
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified
Murray Esler, Sverre E. Kjeldsen, Atul Pathak, et al.
Blood Pressure (2022) Vol. 31, Iss. 1, pp. 210-224
Open Access | Times Cited: 16
A Correlative Relationship Between Heart Failure and Cognitive Impairment: A Narrative Review
Myung Soo Park, Eung Ju Kim
Journal of Korean Medical Science (2023) Vol. 38, Iss. 39
Open Access | Times Cited: 10
For Debate: The 2023 European Society of Hypertension guidelines - cause for concern
Eduard Shantsila, DG Beevers, Gregory Y.H. Lip
Journal of Hypertension (2024) Vol. 42, Iss. 6, pp. 948-950
Open Access | Times Cited: 2
Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial
Philip Leissner, Katarina Mars, Sophia Humphries, et al.
European Heart Journal Acute Cardiovascular Care (2024)
Open Access | Times Cited: 2
Real-world research on beta-blocker usage trends in China and safety exploration based on the FDA Adverse Event Reporting System (FAERS)
Yilong Yan, Wentao An, Shenghui Mei, et al.
BMC Pharmacology and Toxicology (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
β‐Blockers and risk of neuropsychiatric disorders: A systematic review and meta‐analysis
Lujain Ez Eddin, Rebecca Preyra, Fatemeh Ahmadi, et al.
British Journal of Clinical Pharmacology (2024)
Open Access | Times Cited: 2
Spectrum and prevalence of side effects and complications with guideline-directed therapies for congenital long QT syndrome
Katherine Martinez, Sahej Bains, John R. Giudicessi, et al.
Heart Rhythm (2022) Vol. 19, Iss. 10, pp. 1666-1672
Open Access | Times Cited: 12
Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer’s Disease and Parkinson’s Dementia: Systematic Review and Meta-Analysis
Nadine Bittner, Cleo S. M. Funk, Alexander Schmidt, et al.
Drugs & Aging (2023) Vol. 40, Iss. 11, pp. 953-964
Open Access | Times Cited: 6
Antihypertensive Drug Use and the Risk of Depression: A Systematic Review and Network Meta-analysis
Ying Li, Yuanming Fan, Yangyang Sun, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top